ondansetron has been researched along with Bulimia Nervosa in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Bulimia Nervosa: An eating disorder that is characterized by a cycle of binge eating (BULIMIA or bingeing) followed by inappropriate acts (purging) to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Double-blind treatment of severe bulimia nervosa subjects with ONDAN resulted in a rapid and significant decrease in binge-eating and vomiting compared to placebo controls." | 2.43 | Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms. ( Eckert, ED; Faris, PL; Goodale, RL; Hartman, BK; Kim, SW; Meller, WH; Pardo, JV, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faris, PL | 1 |
| Eckert, ED | 1 |
| Kim, SW | 1 |
| Meller, WH | 1 |
| Pardo, JV | 1 |
| Goodale, RL | 1 |
| Hartman, BK | 1 |
1 review available for ondansetron and Bulimia Nervosa
| Article | Year |
|---|---|
Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms.
Topics: Bulimia Nervosa; Depression; Humans; Neurons, Afferent; Ondansetron; Pain; Pain Measurement; Seroton | 2006 |